Adopting a personalized approach to blood monitoring in patients with psoriasis prescribed biologic therapy: a retrospective single-centre review of real-world data

Six-monthly blood monitoring is frequently carried out for patients prescribed biological therapy for psoriasis in the UK. Through the analysis of blood results from a cohort of such patients, we demonstrated that a more targeted and coordinated approach to blood monitoring could be implemented, which would subsequently reduce carbon emissions, associated healthcare costs and the impact on patients’ employment.